Literature DB >> 21866433

Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.

Fulvio Stacul1, Aart J van der Molen, Peter Reimer, Judith A W Webb, Henrik S Thomsen, Sameh K Morcos, Torsten Almén, Peter Aspelin, Marie-France Bellin, Olivier Clement, Gertraud Heinz-Peer.   

Abstract

PURPOSE: The Contrast Media Safety Committee (CMSC) of the European Society of Urogenital Radiology (ESUR) has updated its 1999 guidelines on contrast medium-induced nephropathy (CIN). AREAS COVERED: Topics reviewed include the definition of CIN, the choice of contrast medium, the prophylactic measures used to reduce the incidence of CIN, and the management of patients receiving metformin. Key Points • Definition, risk factors and prevention of contrast medium induced nephropathy are reviewed. • CIN risk is lower with intravenous than intra-arterial iodinated contrast medium. • eGFR of 45 ml/min/1.73 m (2) is CIN risk threshold for intravenous contrast medium. • Hydration with either saline or sodium bicarbonate reduces CIN incidence. • Patients with eGFR ≥ 60 ml/min/1.73 m (2) receiving contrast medium can continue metformin normally.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21866433     DOI: 10.1007/s00330-011-2225-0

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  153 in total

1.  Use of intravenous contrast agents in patients receiving metformin.

Authors:  Rajesh Gupta
Journal:  Radiology       Date:  2002-10       Impact factor: 11.105

Review 2.  Strategies to reduce the risk of contrast-induced nephropathy.

Authors:  Fulvio Stacul; Andy Adam; Christoph R Becker; Charles Davidson; Norbert Lameire; Peter A McCullough; James Tumlin
Journal:  Am J Cardiol       Date:  2006-03-20       Impact factor: 2.778

3.  Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.

Authors:  George Dangas; Ioannis Iakovou; Eugenia Nikolsky; Eve D Aymong; Gary S Mintz; Nicholas N Kipshidze; Alexandra J Lansky; Issam Moussa; Gregg W Stone; Jeffrey W Moses; Martin B Leon; Roxana Mehran
Journal:  Am J Cardiol       Date:  2005-01-01       Impact factor: 2.778

4.  Systemic gadolinium toxicity in patients with renal insufficiency and renal failure: retrospective analysis of an initial experience.

Authors:  T M Arsenault; B F King; J W Marsh; J A Goodman; A L Weaver; C P Wood; R L Ehman
Journal:  Mayo Clin Proc       Date:  1996-12       Impact factor: 7.616

5.  N-Acetylcysteine does not artifactually lower plasma creatinine concentration.

Authors:  Michael Haase; Anja Haase-Fielitz; Sujiva Ratnaike; Michael C Reade; Sean M Bagshaw; Stanislao Morgera; Duska Dragun; Rinaldo Bellomo
Journal:  Nephrol Dial Transplant       Date:  2008-01-17       Impact factor: 5.992

6.  Safety of gadolinium contrast angiography in patients with chronic renal insufficiency.

Authors:  Albert D Sam; Mark D Morasch; Jeremy Collins; Gina Song; Richard Chen; F Scott Pereles
Journal:  J Vasc Surg       Date:  2003-08       Impact factor: 4.268

7.  Introducing estimated glomerular filtration rate (eGFR) into clinical practice in the UK: implications for the use of metformin.

Authors:  R E Warren; M W J Strachan; S Wild; J A McKnight
Journal:  Diabet Med       Date:  2007-03-15       Impact factor: 4.359

8.  Effects of gadopentetate dimeglumine and gadodiamide on serum calcium, magnesium, and creatinine measurements.

Authors:  Hong Lei Zhang; Hale Ersoy; Martin R Prince
Journal:  J Magn Reson Imaging       Date:  2006-03       Impact factor: 4.813

Review 9.  Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis.

Authors:  Sankar D Navaneethan; Sonal Singh; Suresh Appasamy; Richard E Wing; Ashwini R Sehgal
Journal:  Am J Kidney Dis       Date:  2008-11-22       Impact factor: 8.860

10.  Contrast-induced nephropathy and long-term adverse events: cause and effect?

Authors:  Richard J Solomon; Roxana Mehran; Madhu K Natarajan; Serge Doucet; Richard E Katholi; Cezar S Staniloae; Samin K Sharma; Marino Labinaz; Joseph L Gelormini; Brendan J Barrett
Journal:  Clin J Am Soc Nephrol       Date:  2009-06-25       Impact factor: 8.237

View more
  263 in total

Review 1.  Are intravenous injections of contrast media really less nephrotoxic than intra-arterial injections?

Authors:  Ulf Nyman; Torsten Almén; Bo Jacobsson; Peter Aspelin
Journal:  Eur Radiol       Date:  2012-02-04       Impact factor: 5.315

2.  Identifying the Adamkiewicz artery using 3-T time-resolved magnetic resonance angiography: its role in addition to multidetector computed tomography angiography.

Authors:  Hidenobu Takagi; Hideki Ota; Yutaka Natsuaki; Yoshiaki Komori; Koki Ito; Yoshikatsu Saiki; Kei Takase
Journal:  Jpn J Radiol       Date:  2015-10-26       Impact factor: 2.374

Review 3.  Contrast-induced nephropathy in CT: incidence, risk factors and strategies for prevention.

Authors:  Shu Min Tao; Julian L Wichmann; U Joseph Schoepf; Stephen R Fuller; Guang Ming Lu; Long Jiang Zhang
Journal:  Eur Radiol       Date:  2015-12-18       Impact factor: 5.315

4.  Endovascular management of iatrogenic renal arterial lesions and clinical outcomes.

Authors:  Serkan Güneyli; Mustafa Gök; Halil Bozkaya; Celal Çınar; Arastu Tizro; Mehmet Korkmaz; Yiğit Akın; Mustafa Parıldar; İsmail Oran
Journal:  Diagn Interv Radiol       Date:  2015 May-Jun       Impact factor: 2.630

Review 5.  Update on the treatment of type 2 diabetes mellitus.

Authors:  Juan José Marín-Peñalver; Iciar Martín-Timón; Cristina Sevillano-Collantes; Francisco Javier Del Cañizo-Gómez
Journal:  World J Diabetes       Date:  2016-09-15

6.  The incidence of contrast-induced nephropathy (CIN) following transarterial chemoembolisation (TACE) in patients with hepatocellular carcinoma (HCC).

Authors:  Katsumi Hayakawa; Masato Tanikake; Toshihiko Kirishima; Naomi Yoshinami; Hiroyuki Shintani; Eiji Yamamoto; Taisuke Morimoto
Journal:  Eur Radiol       Date:  2014-02-13       Impact factor: 5.315

7.  Iodinated contrast media cause direct tubular cell damage, leading to oxidative stress, low nitric oxide, and impairment of tubuloglomerular feedback.

Authors:  Zhi Zhao Liu; Kristin Schmerbach; Yuan Lu; Andrea Perlewitz; Tatiana Nikitina; Kathleen Cantow; Erdmann Seeliger; Pontus B Persson; Andreas Patzak; Ruisheng Liu; Mauricio M Sendeski
Journal:  Am J Physiol Renal Physiol       Date:  2014-01-15

8.  Brain natriuretic peptide for prevention of contrast-inducednephropathy: a meta-analysis of randomized controlled trials.

Authors:  Xue-Biao Wei; Lei Jiang; Xin-Rong Liu; Dan-Qing Yu; Ning Tan; Ji-Yan Chen; Ying-Ling Zhou; Peng-Cheng He; Yuan-Hui Liu
Journal:  Eur J Clin Pharmacol       Date:  2016-10-01       Impact factor: 2.953

9.  Effect of No Prehydration vs Sodium Bicarbonate Prehydration Prior to Contrast-Enhanced Computed Tomography in the Prevention of Postcontrast Acute Kidney Injury in Adults With Chronic Kidney Disease: The Kompas Randomized Clinical Trial.

Authors:  Rohit J Timal; Judith Kooiman; Yvo W J Sijpkens; Jean-Paul P M de Vries; Iris J A M Verberk-Jonkers; Harald F H Brulez; Marjolijn van Buren; Aart J van der Molen; Suzanne C Cannegieter; Hein Putter; Wilbert B van den Hout; J Wouter Jukema; Ton J Rabelink; Menno V Huisman
Journal:  JAMA Intern Med       Date:  2020-04-01       Impact factor: 21.873

10.  Dextran coated bismuth-iron oxide nanohybrid contrast agents for computed tomography and magnetic resonance imaging.

Authors:  Pratap C Naha; Ajlan Al Zaki; Elizabeth Hecht; Michael Chorny; Peter Chhour; Eric Blankemeyer; Douglas M Yates; Walter R T Witschey; Harold I Litt; Andrew Tsourkas; David P Cormode
Journal:  J Mater Chem B       Date:  2014-12-14       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.